Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/936
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMacekova, Zuzana-
dc.contributor.authorKrivosova, Michaela-
dc.contributor.authorViola, Reka-
dc.contributor.authorZufkova, Viera-
dc.contributor.authorKlimas, Jan-
dc.contributor.authorSnopkova, Miroslava-
dc.date.accessioned2026-03-18T11:26:31Z-
dc.date.available2026-03-18T11:26:31Z-
dc.date.issued2025-02-13-
dc.identifier.issn1886-3655-
dc.identifier.issn1885-642X-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/936-
dc.description17 pages: Illustrations Includes bibliographical referencesen_US
dc.description.abstractBackground: Community pharmacists are often the most accessible healthcare professionals, and community pharmacies provide opportunities for patient counselling, chronic disease management, support with non‑pharmaceutical interventions, safe medication use recommendations, and prevention of drug‑related problems. Objective: This review summarises the different types of advanced pharmaceutical care interventions that pharmacists provide in community pharmacy settings, evaluates their feasibility and benefits for both patients and public health, and assesses their impact on the evolution of pharmaceutical practice within community pharmacies. Methods: A literature search was conducted using PubMed to identify studies on pharmaceutical services delivered in community pharmacies, while excluding hospital and clinical pharmacy interventions. Results: The review highlights a range of pharmaceutical services tailored to various patient groups and disease types. The earliest documented advanced services focused on interventions for cardiovascular diseases and asthma, which remain well‑studied with clear positive health outcomes. Research on other services exists but is less extensive and often depends on intervention duration and collaboration with physicians. Conclusions: Advanced pharmaceutical services represent a shift beyond traditional dispensing roles, emphasising interventions based on patient‑specific needs. However, the wide variety of services and inconsistent research findings make it difficult to derive universal practice recommendations. Services addressing cardiovascular conditions are among the most promising candidates for internationally standardised community pharmacy interventions.en_US
dc.language.isoenen_US
dc.subjectpharmaceutical serviceen_US
dc.subjectpharmacist interventionen_US
dc.subjectcommunity pharmacy reviewen_US
dc.subjectpharmaceutical advanced servicesen_US
dc.titleAdvanced pharmaceutical services in community pharmacies /en_US
dc.typeArticleen_US
Appears in Collections:Pharmacy

Files in This Item:
File Description SizeFormat 
3073.pdf1.98 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.